Tag archives for: FDA,

Up close view of a microscope offering different levels of zoom and focus

Working to improve a promising new diabetes drug

Categories: Diabetes  /  News  /  Research

A new type of drug that has been the focus of much study by San Antonio researchers takes a fairly straightforward approach to treating diabetes. It sends excess sugar down the drain. Literally. Over the past two years, three different oral drugs in a class known as SGLT2 inhibitors have been approved by the U.S. Food and Drug Administration — and more are on the way, said Dr. Eugenio Cersosimo, associate professor of medicine at the UT Health Science Center, and clinical research director at University Health System’s Texas Diabetes Institute. While the liver, pancreas, muscle and fat cells all …Read More >

Tags: , , ,